Safety and Immunogenicity (Non-inferiority) of a Purified Chick Embryo Cell Vaccine Vaccine Administered in Two Different Schedules (Conventional Versus Abbreviated Schedule)
Clinical trial NCT00825305 · COMPLETED
Trial details
- NCT number
- NCT00825305
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2008-12-01
- Enrollment
- 825
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.